Despite this, we believe that our study provided clinically relevant findings concerning the utility of methylation analysis of the promising pan-cancer biomarkers SEPT9 and SHOX2 in the diagnostic setup of PCa. This evidence concerns the gene SEPTIN9 and posterior cortical atrophy.